FeesSafety
Pluang+

NexGold reports strong gold intersections in Nova Scotia's Goldboro project infill drilling program

Market News
03 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
NexGold reports strong gold intersections in Nova Scotia's Goldboro project infill drilling program

NexGold Mining Corp. announced successful results from its Reverse Circulation Infill Drill Program at the Goldboro Gold Project in Nova Scotia, revealing significant gold grades such as 4.16 g/t over 7 meters and 2.84 g/t over 7 meters in the West Pit area. This program aims to increase confidence in mineral resource estimates and support future mine planning, with results expected to contribute to an updated Feasibility Study due later in 2026. Ongoing site development activities continue as NexGold advances toward a construction decision for the project.

NexGold's recent drill results at Goldboro provide context for readers following gold exploration news. For readers following Basic Materials-sector stocks on Pluang, here is the market snapshot as of Nov 03, 2026 17:51 WIB: out of 83 priced US stocks, 22 rose and 57 fell. Among notable movers, TECK traded at USD 61.00 with a 1-day decline of 2.77% and a typical hold time of 22 days, while EXK was priced at USD 7.03, down 2.77%, but saw a Pluang order activity skewed towards buying at 62%. HYMC closed at USD 15.88, down 2.76%, with the shortest typical hold time of 11 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App